Neurorehabilitation and Assistive Device - Global 麻豆原创 Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB510241824

Publication Date:

October 17, 2024

Pages:

131

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

Neurorehabilitation and assistive devices refer to tools, equipment, and technologies designed to aid individuals who have experienced neurological injuries or disorders in regaining or improving their physical and cognitive functions. These devices are an integral part of neurorehabilitation programs and are aimed at enhancing the quality of life and independence of individuals with neurological impairments.
The global market for Neurorehabilitation and Assistive Device was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The integration of cutting-edge technologies such as robotics, virtual reality (VR), augmented reality (AR), and artificial intelligence (AI) has significantly enhanced the effectiveness of neurorehabilitation and assistive devices. These technologies provide personalized and interactive rehabilitation experiences.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Neurorehabilitation and Assistive Device, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Neurorehabilitation and Assistive Device by region & country, by Type, and by Application.
The Neurorehabilitation and Assistive Device market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neurorehabilitation and Assistive Device.
麻豆原创 Segmentation
By Company
Medtronic
Abbott Laboratories
Boston Scientific
Bioness
Hocoma
Neuronetics
Magstim
Ekso Bionics
Alter G
MagVenture
Tyromotion
Soterix Medical
Neuroelectrics
Bionik Laboratories
Helius Medical
Segment by Type:
Brain Neurorehabilitation and Assistive Device
Arms Neurorehabilitation and Assistive Device
Legs Neurorehabilitation and Assistive Device
Other
Segment by Application
Hospital
Rehabilitation Center
Other
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Neurorehabilitation and Assistive Device manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Neurorehabilitation and Assistive Device in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Neurorehabilitation and Assistive Device in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Neurorehabilitation and Assistive Device Product Introduction
1.2 Global Neurorehabilitation and Assistive Device 麻豆原创 Size Forecast
1.3 Neurorehabilitation and Assistive Device 麻豆原创 Trends & Drivers
1.3.1 Neurorehabilitation and Assistive Device Industry Trends
1.3.2 Neurorehabilitation and Assistive Device 麻豆原创 Drivers & Opportunity
1.3.3 Neurorehabilitation and Assistive Device 麻豆原创 Challenges
1.3.4 Neurorehabilitation and Assistive Device 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Neurorehabilitation and Assistive Device Players Revenue Ranking (2023)
2.2 Global Neurorehabilitation and Assistive Device Revenue by Company (2019-2024)
2.3 Key Companies Neurorehabilitation and Assistive Device Manufacturing Base Distribution and Headquarters
2.4 Key Companies Neurorehabilitation and Assistive Device Product Offered
2.5 Key Companies Time to Begin Mass Production of Neurorehabilitation and Assistive Device
2.6 Neurorehabilitation and Assistive Device 麻豆原创 Competitive Analysis
2.6.1 Neurorehabilitation and Assistive Device 麻豆原创 Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Neurorehabilitation and Assistive Device Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neurorehabilitation and Assistive Device as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Brain Neurorehabilitation and Assistive Device
3.1.2 Arms Neurorehabilitation and Assistive Device
3.1.3 Legs Neurorehabilitation and Assistive Device
3.1.4 Other
3.2 Global Neurorehabilitation and Assistive Device Sales Value by Type
3.2.1 Global Neurorehabilitation and Assistive Device Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Neurorehabilitation and Assistive Device Sales Value, by Type (2019-2030)
3.2.3 Global Neurorehabilitation and Assistive Device Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Rehabilitation Center
4.1.3 Other
4.2 Global Neurorehabilitation and Assistive Device Sales Value by Application
4.2.1 Global Neurorehabilitation and Assistive Device Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Neurorehabilitation and Assistive Device Sales Value, by Application (2019-2030)
4.2.3 Global Neurorehabilitation and Assistive Device Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Neurorehabilitation and Assistive Device Sales Value by Region
5.1.1 Global Neurorehabilitation and Assistive Device Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Neurorehabilitation and Assistive Device Sales Value by Region (2019-2024)
5.1.3 Global Neurorehabilitation and Assistive Device Sales Value by Region (2025-2030)
5.1.4 Global Neurorehabilitation and Assistive Device Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Neurorehabilitation and Assistive Device Sales Value, 2019-2030
5.2.2 North America Neurorehabilitation and Assistive Device Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Neurorehabilitation and Assistive Device Sales Value, 2019-2030
5.3.2 Europe Neurorehabilitation and Assistive Device Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Neurorehabilitation and Assistive Device Sales Value, 2019-2030
5.4.2 Asia Pacific Neurorehabilitation and Assistive Device Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Neurorehabilitation and Assistive Device Sales Value, 2019-2030
5.5.2 South America Neurorehabilitation and Assistive Device Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Neurorehabilitation and Assistive Device Sales Value, 2019-2030
5.6.2 Middle East & Africa Neurorehabilitation and Assistive Device Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Neurorehabilitation and Assistive Device Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Neurorehabilitation and Assistive Device Sales Value
6.3 United States
6.3.1 United States Neurorehabilitation and Assistive Device Sales Value, 2019-2030
6.3.2 United States Neurorehabilitation and Assistive Device Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Neurorehabilitation and Assistive Device Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Neurorehabilitation and Assistive Device Sales Value, 2019-2030
6.4.2 Europe Neurorehabilitation and Assistive Device Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Neurorehabilitation and Assistive Device Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Neurorehabilitation and Assistive Device Sales Value, 2019-2030
6.5.2 China Neurorehabilitation and Assistive Device Sales Value by Type (%), 2023 VS 2030
6.5.3 China Neurorehabilitation and Assistive Device Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Neurorehabilitation and Assistive Device Sales Value, 2019-2030
6.6.2 Japan Neurorehabilitation and Assistive Device Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Neurorehabilitation and Assistive Device Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Neurorehabilitation and Assistive Device Sales Value, 2019-2030
6.7.2 South Korea Neurorehabilitation and Assistive Device Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Neurorehabilitation and Assistive Device Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Neurorehabilitation and Assistive Device Sales Value, 2019-2030
6.8.2 Southeast Asia Neurorehabilitation and Assistive Device Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Neurorehabilitation and Assistive Device Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Neurorehabilitation and Assistive Device Sales Value, 2019-2030
6.9.2 India Neurorehabilitation and Assistive Device Sales Value by Type (%), 2023 VS 2030
6.9.3 India Neurorehabilitation and Assistive Device Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Medtronic
7.1.1 Medtronic Profile
7.1.2 Medtronic Main Business
7.1.3 Medtronic Neurorehabilitation and Assistive Device Products, Services and Solutions
7.1.4 Medtronic Neurorehabilitation and Assistive Device Revenue (US$ Million) & (2019-2024)
7.1.5 Medtronic Recent Developments
7.2 Abbott Laboratories
7.2.1 Abbott Laboratories Profile
7.2.2 Abbott Laboratories Main Business
7.2.3 Abbott Laboratories Neurorehabilitation and Assistive Device Products, Services and Solutions
7.2.4 Abbott Laboratories Neurorehabilitation and Assistive Device Revenue (US$ Million) & (2019-2024)
7.2.5 Abbott Laboratories Recent Developments
7.3 Boston Scientific
7.3.1 Boston Scientific Profile
7.3.2 Boston Scientific Main Business
7.3.3 Boston Scientific Neurorehabilitation and Assistive Device Products, Services and Solutions
7.3.4 Boston Scientific Neurorehabilitation and Assistive Device Revenue (US$ Million) & (2019-2024)
7.3.5 Bioness Recent Developments
7.4 Bioness
7.4.1 Bioness Profile
7.4.2 Bioness Main Business
7.4.3 Bioness Neurorehabilitation and Assistive Device Products, Services and Solutions
7.4.4 Bioness Neurorehabilitation and Assistive Device Revenue (US$ Million) & (2019-2024)
7.4.5 Bioness Recent Developments
7.5 Hocoma
7.5.1 Hocoma Profile
7.5.2 Hocoma Main Business
7.5.3 Hocoma Neurorehabilitation and Assistive Device Products, Services and Solutions
7.5.4 Hocoma Neurorehabilitation and Assistive Device Revenue (US$ Million) & (2019-2024)
7.5.5 Hocoma Recent Developments
7.6 Neuronetics
7.6.1 Neuronetics Profile
7.6.2 Neuronetics Main Business
7.6.3 Neuronetics Neurorehabilitation and Assistive Device Products, Services and Solutions
7.6.4 Neuronetics Neurorehabilitation and Assistive Device Revenue (US$ Million) & (2019-2024)
7.6.5 Neuronetics Recent Developments
7.7 Magstim
7.7.1 Magstim Profile
7.7.2 Magstim Main Business
7.7.3 Magstim Neurorehabilitation and Assistive Device Products, Services and Solutions
7.7.4 Magstim Neurorehabilitation and Assistive Device Revenue (US$ Million) & (2019-2024)
7.7.5 Magstim Recent Developments
7.8 Ekso Bionics
7.8.1 Ekso Bionics Profile
7.8.2 Ekso Bionics Main Business
7.8.3 Ekso Bionics Neurorehabilitation and Assistive Device Products, Services and Solutions
7.8.4 Ekso Bionics Neurorehabilitation and Assistive Device Revenue (US$ Million) & (2019-2024)
7.8.5 Ekso Bionics Recent Developments
7.9 Alter G
7.9.1 Alter G Profile
7.9.2 Alter G Main Business
7.9.3 Alter G Neurorehabilitation and Assistive Device Products, Services and Solutions
7.9.4 Alter G Neurorehabilitation and Assistive Device Revenue (US$ Million) & (2019-2024)
7.9.5 Alter G Recent Developments
7.10 MagVenture
7.10.1 MagVenture Profile
7.10.2 MagVenture Main Business
7.10.3 MagVenture Neurorehabilitation and Assistive Device Products, Services and Solutions
7.10.4 MagVenture Neurorehabilitation and Assistive Device Revenue (US$ Million) & (2019-2024)
7.10.5 MagVenture Recent Developments
7.11 Tyromotion
7.11.1 Tyromotion Profile
7.11.2 Tyromotion Main Business
7.11.3 Tyromotion Neurorehabilitation and Assistive Device Products, Services and Solutions
7.11.4 Tyromotion Neurorehabilitation and Assistive Device Revenue (US$ Million) & (2019-2024)
7.11.5 Tyromotion Recent Developments
7.12 Soterix Medical
7.12.1 Soterix Medical Profile
7.12.2 Soterix Medical Main Business
7.12.3 Soterix Medical Neurorehabilitation and Assistive Device Products, Services and Solutions
7.12.4 Soterix Medical Neurorehabilitation and Assistive Device Revenue (US$ Million) & (2019-2024)
7.12.5 Soterix Medical Recent Developments
7.13 Neuroelectrics
7.13.1 Neuroelectrics Profile
7.13.2 Neuroelectrics Main Business
7.13.3 Neuroelectrics Neurorehabilitation and Assistive Device Products, Services and Solutions
7.13.4 Neuroelectrics Neurorehabilitation and Assistive Device Revenue (US$ Million) & (2019-2024)
7.13.5 Neuroelectrics Recent Developments
7.14 Bionik Laboratories
7.14.1 Bionik Laboratories Profile
7.14.2 Bionik Laboratories Main Business
7.14.3 Bionik Laboratories Neurorehabilitation and Assistive Device Products, Services and Solutions
7.14.4 Bionik Laboratories Neurorehabilitation and Assistive Device Revenue (US$ Million) & (2019-2024)
7.14.5 Bionik Laboratories Recent Developments
7.15 Helius Medical
7.15.1 Helius Medical Profile
7.15.2 Helius Medical Main Business
7.15.3 Helius Medical Neurorehabilitation and Assistive Device Products, Services and Solutions
7.15.4 Helius Medical Neurorehabilitation and Assistive Device Revenue (US$ Million) & (2019-2024)
7.15.5 Helius Medical Recent Developments
8 Industry Chain Analysis
8.1 Neurorehabilitation and Assistive Device Industrial Chain
8.2 Neurorehabilitation and Assistive Device Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Neurorehabilitation and Assistive Device Sales Model
8.5.2 Sales Channel
8.5.3 Neurorehabilitation and Assistive Device Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Medtronic
Abbott Laboratories
Boston Scientific
Bioness
Hocoma
Neuronetics
Magstim
Ekso Bionics
Alter G
MagVenture
Tyromotion
Soterix Medical
Neuroelectrics
Bionik Laboratories
Helius Medical

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.